Consolidated financial statements

Consolidated income statements

April 1 to March 31, in CHF million

 

Notes

 

2019/20

 

2018/19

Sales

 

2.2,2.3

 

2,916.9

 

2,763.2

Cost of sales

 

 

 

(833.3)

 

(797.0)

Gross profit

 

 

 

2,083.6

 

1,966.2

Research and development 1)

 

 

 

(167.0)

 

(149.4)

Sales and marketing 1)

 

 

 

(1,074.3)

 

(1,015.7)

General and administration

 

 

 

(309.0)

 

(269.3)

Other income/(expenses), net

 

2.4

 

(23.4)

 

4.4

Operating profit (EBIT) 2)

 

 

 

510.0

 

536.2

Financial income

 

4.2

 

2.9

 

3.4

Financial expenses

 

4.2

 

(12.9)

 

(12.1)

Share of profit/(loss) in associates/joint ventures, net

 

6.2

 

2.4

 

2.1

Income before taxes

 

 

 

502.4

 

529.6

Income taxes

 

5.1

 

(12.9)

 

(69.4)

Income after taxes

 

 

 

489.5

 

460.2

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

Equity holders of the parent

 

 

 

483.2

 

454.1

Non-controlling interests

 

 

 

6.3

 

6.1

 

 

 

 

 

 

 

Basic earnings per share (CHF)

 

2.5

 

7.61

 

6.98

Diluted earnings per share (CHF)

 

2.5

 

7.57

 

6.95

1) Includes acquisition-related amortization of CHF 0.9 million (previous year: CHF 1.0 million) in “Research and development” and CHF 43.5 million (previous year: CHF 45.4 million) in “Sales and marketing”. EBITA (Earnings before financial result, share of profit/(loss) in associates/joint ventures, taxes and acquisition-related amortization) amounts to CHF 554.3 million (previous year: CHF 582.5 million). Refer to Note 2.1

2) Earnings before financial result, share of profit/(loss) in associates/joint ventures and taxes (EBIT).

The Notes are an integral part of the consolidated financial statements.

Dieser Abschnitt ist nur in englischer Sprache verfügbar.